AWM
AMPE

Apollon Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Apollon Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11
Closed -$2K – 734
2020
Q2 		$2K Buy
+11
New +$1.83K ﹤0.01% 663

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Apollon Wealth Management's AMPE Position: Q3 2020 in Review

Apollon Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2020, closing a stake of 11 shares — an estimated $2K sold.

Apollon Wealth Management first reported a position in AMPE in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2020.

  • Apollon Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2020 after selling out during the quarter.
  • Apollon Wealth Management sold 11 Ampio Pharmaceuticals Inc. shares in Q3 2020, an estimated $2K.
  • Apollon Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2020 and held it in 1 quarter.
  • Apollon Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $2K in Q2 2020.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2020.

Based on Apollon Wealth Management's 13F filing for Q3 2020, filed 3 Nov 2020.